Patients with severe MR were more likely to be female, suffer from atrial fibrillation or atrial flutter and anemia, and were more likely treated with a diuretic and a mineralocorticoid-receptor antagonist (MRA). This evidence concerns the gene NR3C2 and miotic rate.